Página 3 - Melhores Terapia direcionada Terapia direcionada - TOP-65 médicos

O Dr. Eckhart Weidemann lidera o setor de Hematologia na Clínica Nordwest – um especialista no tratamento de doenças do sangue com mais de 30 anos de experiência.

• Especializado em casos de linfoma não Hodgkin
• Chefe da hematologia na Clínica Nordwest
• Professor com vasta formação acadêmica

Especializado em procedimentos endoscópicos avançados, o Dr. Erdogan possui experiência em CPRE (Colangiopancreatografia Retrógrada Endoscópica), EUS (Ultrassonografia Endoscópica) e tratamento de DII (Doença Inflamatória Intestinal) no İstinye University Liv Hospital Topkapı.

• Bolsa clínica (fellowship) em gastroenterologia no Hospital da Cidade de Ankara
• Publicou múltiplos artigos de pesquisa sobre o tratamento da doença inflamatória intestinal
• Experiente em miotomia endoscópica peroral (POEM) e dissecção submucosa endoscópica (ESD)
• Contribuinte ativo em periódicos revisados por pares na área de gastroenterologia

Diretor Clínico da Unidade Multidisciplinar de Mama na Kliniken Essen-Mitte – Sherko Kuemmel lidera a pesquisa e o tratamento avançado do câncer de mama.

• 322 publicações revisadas por pares sobre câncer de mama
• Membro do Conselho Executivo da AGO – moldando as diretrizes do câncer de mama
• Lidera ensaios clínicos internacionais como PI Global
• Membro da faculdade ESMO para educação em câncer de mama

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Médico Chefe do Centro de Oncologia no Assuta Medical Center – especialista líder em terapia direcionada.

• Especializa-se em tratamentos de oncologia de precisão
• Vasta experiência com terapias personalizadas contra o câncer
• Trabalha em um dos principais centros oncológicos de Israel

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

O Dr. Lalit realizou com sucesso mais de 10.000 cirurgias de grande porte, com foco em cirurgias oncológicas minimamente invasivas no HCG Manavata Cancer Centre.

• Mais de 10 anos de experiência em oncologia cirúrgica
• Fellowship no Tata Medical Centre com especialidade em câncer gastrointestinal
• Professor Assistente no State Cancer Institute e no Government Cancer Hospital
• Múltiplas publicações nacionais e internacionais
• Abordagem ética e centrada no paciente

O Dr. Shaunak é especialista na base molecular do cancro e possui competências em terapias dirigidas, tendo apresentado investigação no Simpósio de Cancro Gastrointestinal da ASCO.

• Concluiu o DNB em Oncologia Médica no Indraprastha Apollo Hospital
• Apresentou investigação sobre cancro do estômago no simpósio da ASCO
• Palestrante na International Winter School of Oncology no AIIMS
• Trabalha no HCG Manavata Cancer Centre

35 anos de especialização em gestações de alto risco – o Dr. Vatsa trata casos complexos no Fortis Memorial Research Institute.

• Especialista em cirurgias endoscópicas e métodos de diagnóstico
• Especializado na gestão de gestações ectópicas e abortos espontâneos
• Autor de vários artigos sobre oncoginecologia
• Membro da Associação Indiana de Ginecologistas

O Dr. Vinod Raina é especialista em terapia-alvo no Fortis Gurgaon, oferecendo conhecimento focado no tratamento do câncer.

• Oncologista médico com vasta experiência em quimioterapia
• Especializa-se em abordagens de medicina de precisão
• Atende no Fortis Gurgaon, uma instituição de saúde líder

Reconhecido como um dos urologistas líderes da Alemanha pela revista FOCUS – o Professor Truss é especialista em câncer de próstata no «Centro de Carcinoma da Próstata» acreditado.

• 30 anos de experiência em urologia
• Utiliza técnicas assistidas por robótica para cirurgia de próstata precisa e minimamente invasiva
• Publicou em importantes periódicos de urologia na Europa e nos EUA
• Recebedor do Prêmio Jack Lapides e do Prêmio do Congresso da EAU
• Chefe do departamento de urologia na Clínica Dortmund

O Professor Jorg Groticke chefia o Centro de Oncologia e Hematologia no Hospital Bremen Mitte, sendo especializado em malignidades hematológicas e tumores gastrointestinais.

• Especializado em imunologia desde 1987
• Médico sênior no Centro de Medicina Interna desde 2007
• Membro da Sociedade Alemã de Hematologia e Oncologia Médica
• Ministra palestras sobre terapia inovadora contra o câncer na Sociedade de Oncologia de Bremen

A Dra. Joan Albanell Mestres lidera o programa de câncer de mama da HM Delfos e publicou mais de 120 artigos com mais de 9.000 citações.

• MBBS (Bacharelado em Medicina e Cirurgia) pela Universidade Autónoma de Barcelona
• Residência na clínica Vall d'Hebron
• Conduziu pesquisas sobre telomerase em Nova York
• Diretora de pesquisa sobre o câncer em Del Mar
• Membro líder de GEICAM, CIBERONC, AIECA, SEOM